Supply Chain | September 28, 2021
SpeeDx and SynGenis partner for custom oligonucleotide synthesis
The investment will increase SpeeDx internal capacity to scale up manufacturing
The investment will increase SpeeDx internal capacity to scale up manufacturing
Remote screening of diabetic retinopathy can help in early detection, even before there are any noticeable vision changes
Industry leaders to increase patient access to clinical research and scale remote enrollment of participants for trial sponsors to promote increased health equity
Eka Care will provide a six-month complimentary trial period to all members who register before December 31, 2021
The Lancet study said that Sputnik Light showed 78.6 to 83.7 per cent efficacy against Covid-19, significantly higher than most two-shot vaccines
Initially launched in Europe, this new service gives customers access to a range of digital health services and medical professionals and is part of its Digital Access to Care Initiative
The deal is expected to close in the fourth quarter of 2021 and will enable Roche to further expand the portfolio. TIB Molbiol excels in ultra-rapid assay development of emerging infectious diseases
The batch will be distributed in India through a partner of RDIF and Panacea Biotec - Dr. Reddy's Laboratories
Amptron’s R &D is based out of the US and this will enable Max to obtain US and other global certifications. Max will retain the right to market, sell and distribute the products in India.
According to WHO, over 1.5 million people died of TB in 2020
Subscribe To Our Newsletter & Stay Updated
